Home › Compare › SGEN vs STAG

SGEN vs STAG: Dividend Comparison 2026

SGEN yields 0.87% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SGEN wins by $2.6K in total portfolio value
10 years
SGEN
SGEN
● Live price
0.87%
Share price
$228.74
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.9K
Annual income
$92.54
Full SGEN calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — SGEN vs STAG

📍 SGEN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSGENSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SGEN + STAG cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SGEN pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SGEN
Annual income on $10K today (after 15% tax)
$74.32/yr
After 10yr DRIP, annual income (after tax)
$78.66/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, STAG beats the other by $314.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SGEN + STAG for your $10,000?

SGEN: 50%STAG: 50%
100% STAG50/50100% SGEN
Portfolio after 10yr
$19.6K
Annual income
$277.38/yr
Blended yield
1.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SGEN right now

SGEN
Analyst Ratings
14
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$171.82
-24.9% upside vs current
Range: $120.00 — $222.00
Altman Z
23.3
Piotroski
2/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SGEN buys
0
STAG buys
0
No recent congressional trades found for SGEN or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSGENSTAG
Forward yield0.87%3.44% ✓
Annual dividend / share$2.00 ✓$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3% ✓
Portfolio after 10y$20.9K ✓$18.3K
Annual income after 10y$92.54$462.22 ✓
Total dividends collected$902.00 ✓$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$171.82 ✓$45.00

Year-by-year: SGEN vs STAG ($10,000, DRIP)

YearSGEN PortfolioSGEN Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$10,787$87.44$10,665$345.09+$122.00 → SGEN
2$11,631$88.15$11,364$357.70+$267.00 → SGEN
3$12,534$88.82$12,098$370.43+$436.00 → SGEN
4$13,500$89.46$12,869$383.28+$631.00 → SGEN
5$14,536$90.05$13,677$396.23+$859.00 → SGEN
6$15,644$90.62$14,524$409.27+$1.1K → SGEN
7$16,830$91.14$15,411$422.41+$1.4K → SGEN
8$18,100$91.64$16,339$435.61+$1.8K → SGEN
9$19,459$92.11$17,311$448.89+$2.1K → SGEN
10$20,913$92.54$18,327$462.22+$2.6K → SGEN

SGEN vs STAG: Complete Analysis 2026

SGEN — Stock

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Full SGEN Calculator →

STAG — REIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this SGEN vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SGEN vs SCHDSGEN vs JEPISGEN vs OSGEN vs KOSGEN vs MAINSGEN vs PLDSGEN vs EQRSGEN vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.